Replies to post #26719 on $heff's $tation of $tocks & $olid DD

[$heff]

POZN ($10.78)…Vimovo was given high remarks from a Medscape article!

[ronpopeil]

Don't forget that POZN should receive EMEA approval shortly after FDA approval. That should cause another pop for the stock.